Who
Emma Reeve
Director
Company insider
Files Form 4 as: Director, Whitehawk Therapeutics; Director, PTC Therapeutics; Director, Editas Medicine; Chief Financial Officer, Constellation Pharmaceuticals; Corp. VP & Interim CFO, Parexel International.
In numbers
- Trades disclosed
- 189
- Buys
- 0
- Sells
- 28
- Bought
- $0
- Sold
- $10.3M
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 7 Dec 2016
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,040 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,040 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code M | $34K734 at $46.54 | filing |
| 5 Jan 2026filed 6 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $56K734 at $76.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —734 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —734 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code M | $34K734 at $46.54 | filing |
| 5 Jan 2026filed 6 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $56K734 at $76.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,475 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,475 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 3 Dec 2025filed 5 Dec 2025 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —733 at $0.00 | filing |
| 3 Dec 2025filed 5 Dec 2025 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code M | $34K733 at $46.54 | filing |
| 3 Dec 2025filed 5 Dec 2025 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $58K733 at $78.62 | filing |
| 21 Nov 2025filed 25 Nov 2025 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 21 Nov 2025filed 25 Nov 2025 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code M | $512K10,000 at $51.16 | filing |
| 21 Nov 2025filed 25 Nov 2025 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $795K10,000 at $79.50 | filing |
| 12 Nov 2025filed 14 Nov 2025 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,333 at $0.00 | filing |
| 12 Nov 2025filed 14 Nov 2025 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code M | $341K7,333 at $46.54 | filing |
News
PTC Therapeutics (NASDAQ:PTCT) & Aktis Oncology (NASDAQ:AKTS) Head to Head ContrastPTCT · dailypolitical.com · 19 Oct 2026PTC Therapeutics (NASDAQ:PTCT) Director Michael Schmertzler Sells 2,500 Shares of Company StockPTCT · tickerreport.com · 16 Oct 2026PTC Therapeutics (NASDAQ:PTCT) Stock: Insider Mark Elliott Boulding Sells 1,638 SharesPTCT · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Emma Reeve; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.